NL-OMON50023已完成不适用
Heart Failure with Preserved Ejection Fraction (HFpEF), a prospective cohort - HFpEF cohort
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 201
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients referred with exertional dyspnea to the HFpEF clinic from the
- •general HF, general cardiology outpatient clinic or directly from their general
- •practitioners above 18 years that have the ability to give the informed consent
- •and sign it will be included in the cohort and blood and urine samples for the
- •biobank will be obtained. , 20 hypertensive control patients will be included.
- •These are their inclusion criteria:
- •o Age > 50 years
- •o Estimated glomerular filtration reserve (eGFR) >30 ml/min
- •o Body weight<130kg
- •o No coronary artery disease (CAD; coronary stenosis>70% or history of CABG)
- •o No heart failure
- •o Preserved left ventricular ejection fraction (LVEF) (>= 50%) on
- •echocardiography
- •o No left ventricular hypertrophy (lateral and septal left ventricular wall
- •o No left atrium enlargement
- •o No diastolic dysfunction type 2 or 3
- •o Blood pressure >140/90 mmHg or use of anti-hypertensive therapy
- •o Normal cardiac structure and function on echocardiography
排除标准
- •- Inability to give informed consent or refusal to participate in the study
- •- Age <18 years.
研究者
相似试验
已完成
不适用
Whole blood thrombin generation, platelet activation test and platelet-monocyte complex formation to predict hypercoagulability in patients with multiple myelomacancer of plasma cellsPlasma cell myeloma10018865NL-OMON48375Synapse Research Institute42
已完成
不适用
Superior capsular reconstruction of irreparable degenerative rotator cuff tears of the shoulder: a multi-center,comparative, prospective, observational follow-up studyNL-OMON48664Viecuri Medisch Centrum voor Noord-Limburg17
已完成
不适用
Validation of the Dutch version of the Hip Outcome ScoreNL-OMON47747Reinier de Graaf Groep136
已完成
不适用
A Phase 1/1b First-in-human Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR439459 Administered Intravenously as Monotherapy and in Combination with cemiplimab in Adult Patients with Advanced Solid TumorsAdvanced solid tumors10027655NL-OMON55468Genzyme Europe BV12
已完成
3 期
Phase III, pivotal, multicentre, randomised, double-blind controlled Study to evaluate the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Early Stage Non Traumatic Osteonecrosis of the Femoral Head.NL-OMON45063Bone Therapeutics6